Biocardia
Price & Volume
Stats
See more52W Range | $0.75-$1.50 |
Market Cap | $13.6M |
Shares Short | 678,398 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$4.1M |
Diluted EPS | -$0.64 |
News
See moreYahoo Finance • 16 days ago
BioCardia Announces FDA Acceptance of De Novo Pre-Submission Package for Helix™ Catheter Marketing Clearance FDA Substantive Review and Meeting Expected this Quarter
Yahoo Finance • 3 months ago
BioCardia to Host Q2 2026 Financial Results and Corporate Update Conference Call on August 12, 2026
Yahoo Finance • 3 months ago
Congestive Heart Failure Market to Register Immense Growth at a CAGR of 8% During the Forecast Period (2026-2036) | DelveInsight
Yahoo Finance • 5 months ago
Pre-Market Movers: TNGX, WOK, GOCO Set The Path
About
CEO | Dr. Peter A. Altman Ph.D. |
Address | 320 Soquel Way, Sunnyvale, CA, United States, 94085 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 17 |